Answers are grounded in this paper and cite their sources.
Bacterial adaptive immunity hinges on CRISPR-Cas systems that provide DNA-encoded, RNA-mediated targeting of exogenous nucleic acids. A plethora of CRISPR molecular machines occur broadly in prokaryotic genomes, with a diversity of Cas nucleases that can be repurposed for various applications.
No takes yet. Share an insight, caveat, or question.
Rodolphe Barrangou (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: